Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 2 , Pages 139-145 , June 2008

Polystyrene nanoparticle trafficking across alveolar epithelium

  • Nazanin R. Yacobi, MS

      Affiliations

    • Mork Family Department of Chemical Engineering and Materials Science, University of Southern California
    • Will Rogers Institute, Pulmonary Research Center, University of Southern California, Los Angeles, California, USA
    • Corresponding Author InformationCorresponding author. Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
    • ,
  • Lucas DeMaio, PhD

      Affiliations

    • Department of Medicine, University of Southern California
    • Will Rogers Institute, Pulmonary Research Center, University of Southern California, Los Angeles, California, USA
    • ,
  • Jiansong Xie, MD, PhD

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, University of Southern California
    • ,
  • Sarah F. Hamm-Alvarez, PhD

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, University of Southern California
    • ,
  • Zea Borok, MD

      Affiliations

    • Department of Medicine, University of Southern California
    • Will Rogers Institute, Pulmonary Research Center, University of Southern California, Los Angeles, California, USA
    • ,
  • Kwang-Jin Kim, PhD

      Affiliations

    • Department of Medicine, University of Southern California
    • Department of Pharmacology and Pharmaceutical Sciences, University of Southern California
    • Will Rogers Institute, Pulmonary Research Center, University of Southern California, Los Angeles, California, USA
    • ,
  • Edward D. Crandall, PhD, MD

      Affiliations

    • Mork Family Department of Chemical Engineering and Materials Science, University of Southern California
    • Department of Medicine, University of Southern California
    • Will Rogers Institute, Pulmonary Research Center, University of Southern California, Los Angeles, California, USA

Received 13 December 2007 ,Accepted 18 February 2008.

References 

  1. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105:411–414
  2. Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med. 2001;164:1665–1668
  3. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65:1531–1543
  4. Oberdorster G, Gelein RM, Ferin J, Weiss B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles?. Inhal Toxicol. 1995;7:111–124
  5. Wichmann HE, Spix C, Tuch T, Wolke G, Peters A, Heinrich J, et al. Daily mortality and fine and ultrafine particles in Erfurt, Germany Part I: role of particle number and particle mass. Res Rep Health Eff Inst. 2000;98:5–94
  6. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103:2810–2815
  7. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–839
  8. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA. 2005;294:3003–3010
  9. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci. 2004;77:347–357
  10. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 2004;77:117–125
  11. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–627
  12. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health. 2001;74:1–8
  13. Wottrich R, Diabate S, Krug HF. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health. 2004;207:353–361
  14. Monn C, Fendt R, Koller T. Ambient PM(10) extracts inhibit phagocytosis of defined inert model particles by alveolar macrophages. Inhal Toxicol. 2002;14:369–385
  15. Bosquillon C, Preat V, Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Control Release. 2004;96:233–244
  16. Kim KJ, Borok Z, Crandall ED. A useful in vitro model for transport studies of alveolar epithelial barrier. Pharm Res. 2001;18:253–255
  17. Elbert KJ, Schafer UF, Schafers HJ, Kim KJ, Lee VH, Lehr CM. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res. 1999;16:601–608
  18. Evans MJ, Cabral LJ, Stephens RJ, Freeman G. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol. 1975;22:142–150
  19. Cheek JM, Evans MJ, Crandall ED. Type I cell-like morphology in tight alveolar epithelial monolayers. Exp Cell Res. 1989;184:375–387
  20. Danto SI, Zabski SM, Crandall ED. Reactivity of alveolar epithelial cells in primary culture with type I cell monoclonal antibodies. Am J Respir Cell Mol Biol. 1992;6:296–306
  21. Borok Z, Danto SI, Zabski SM, Crandall ED. Defined medium for primary culture de novo of adult rat alveolar epithelial cells. In Vitro Cell Dev Biol Anim. 1994;30A:99–104
  22. Borok Z, Hami A, Danto SI, Zabski SM, Crandall ED. Rat serum inhibits progression of alveolar epithelial cells toward the type I cell phenotype in vitro. Am J Respir Cell Mol Biol. 1995;12:50–55
  23. Borok Z, Lubman RL, Danto SI, Zhang XL, Zabski SM, King LS, et al. Keratinocyte growth factor modulates alveolar epithelial cell phenotype in vitro: expression of aquaporin 5. Am J Respir Cell Mol Biol. 1998;18:554–561
  24. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002;65:1513–1530
  25. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, et al. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol. 2006;18:733–740
  26. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109:547–551
  27. Hoet PH, Bruske-Hohlfeld I, Salata OV. Nanoparticles—known and unknown health risks. J Nanobiotechnol. 2004;2:12
  28. Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res. 1992;9:1029–1034
  29. El-Shabouri MH. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm. 2002;249:101–108
  30. Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001;52:117–126
  31. Yacobi NR, Phuleria HC, Demaio L, Liang CH, Peng CA, Sioutas C, et al. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro. 2007;21:1373–1381
  32. des Rieux A, Ragnarsson EG, Gullberg E, Preat V, Schneider YJ, Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci. 2005;25:455–465
  33. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113:1555–1560
  34. Geiser M, Rothen-Rutishauser B, Kapp N, Gehr P, Schurch S, Kreyling W, et al. Ultrafine particles. Environ Health Perspect. 2006;114:A212–A213
  35. Ferin J, Oberdorster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol. 1992;6:535–542
  36. Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990;42:821–826
  37. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662–668
  38. Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl. 2006;45:577–581
  39. Campbell L, Hollins AJ, Al-Eid A, Newman GR, von Ruhl C, Gumbleton M. Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures. Biochem Biophys Res Commun. 1999;262:744–751
  40. Newman GR, Campbell L, von Ruhl C, Jasani B, Gumbleton M. Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res. 1999;295:111–120
  41. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794–1807
  42. Stearns RC, Paulauskis JD, Godleski JJ. Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol. 2001;24:108–115

 This work was supported in part by the Hastings Foundation, the Whittier Foundation, and research grants EY 11386, EY 17923, ES 07048, HL 38578, HL 38621, HL 38658, HL 62569, and HL 64365 from the National Institutes of Health and 0730280N from the American Heart Association. Crandall is Hastings Professor and Kenneth T. Norris Jr. Chair of Medicine.

PII: S1549-9634(08)00032-4

doi: 10.1016/j.nano.2008.02.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 2 , Pages 139-145 , June 2008

Article Tools

* Image Usage & Resolution